NRC HEALTH - National Research Ord Shs (NRC)

CUSIP: 637372202

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / National Research Ord Shs
Shares outstanding
22,716,513
Total 13F shares
11,503,564
Share change
-374,239
Total reported value
$147,284,867
Put/Call ratio
0%
Price per share
$12.80
Number of holders
122
Value change
-$6,206,822
Number of buys
47
Number of sells
73

Security key

637372202

Report period

Q1 2025

Institutions

122

Top holders

10

Top shareholders of NRC - NRC HEALTH - National Research Ord Shs (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Common Property Trust
3/4/5 13D/G
10%+ Owner · Beans Patrick E.
46%
from 13D/G
8,609,601
$113,388,445 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
4.4%
from 13D/G
1,206,454
$21,281,849 31 Dec 2024
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
13F
Company
13%
3,033,427
$53,509,655 31 Dec 2024
13F
VANGUARD GROUP INC
13F
Company
4.2%
952,664
$16,804,993 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
4%
917,063
$16,177,008 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.6%
582,479
$10,274,722 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
435,707
$7,686,959 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.8%
404,886
$7,142,189 31 Dec 2024
13F
STATE STREET CORP
13F
Company
1.6%
358,082
$6,359,142 31 Dec 2024
13F
QV Investors Inc.
13F
Company
1.6%
354,360
$6,251,000 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
1.3%
293,755
$5,181,837 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.96%
217,212
$3,831,616 31 Dec 2024
13F
iA Global Asset Management Inc.
13F
Company
0.83%
187,520
$3,308,000 31 Dec 2024
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.71%
161,750
$2,853,270 31 Dec 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.63%
143,145
$2,525,070 31 Dec 2024
13F
Northwest & Ethical Investments L.P.
13F
Company
0.57%
129,200
$2,279,088 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.55%
124,852
$2,202,398 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.55%
124,711
$2,199,902 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.49%
111,657
$1,969,630 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.44%
100,922
$1,777,509 31 Dec 2024
13F
COMERICA BANK
13F
Company
0.41%
94,137
$1,660,577 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.36%
81,961
$1,445,792 31 Dec 2024
13F
ALGERT GLOBAL LLC
13F
Company
0.35%
79,218
$1,397,000 31 Dec 2024
13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
13F
Company
0.34%
77,895
$1,374,068 31 Dec 2024
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.32%
73,117
$1,289,791 31 Dec 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.29%
65,970
$1,163,711 31 Dec 2024
13F
SEI INVESTMENTS CO
13F
Company
0.27%
61,370
$1,082,567 31 Dec 2024
13F
Creative Planning
13F
Company
0.27%
60,540
$1,067,926 31 Dec 2024
13F
Retirement System Of Texas Teacher
13F
Individual
0.25%
57,826
$1,020,000 31 Dec 2024
13F
Willis Investment Counsel
13F
Company
0.24%
55,247
$974,557 31 Dec 2024
13F
TOWNSQUARE CAPITAL LLC
13F
Company
0.22%
49,845
$879,256 31 Dec 2024
13F
BESSEMER GROUP INC
13F
Company
0.21%
47,110
$831,000 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.2%
44,602
$786,779 31 Dec 2024
13F
ALPS ADVISORS INC
13F
Company
0.19%
43,656
$770,092 31 Dec 2024
13F
Williams Jones Wealth Management, LLC.
13F
Company
0.18%
41,998
$740,845 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.18%
41,691
$735,429 31 Dec 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.18%
40,252
$710,046 31 Dec 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.17%
39,254
$692,441 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.17%
39,235
$692,106 31 Dec 2024
13F
US BANCORP \DE\
13F
Company
0.17%
38,577
$680,498 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.17%
38,565
$680,286 31 Dec 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.15%
34,552
$609,547 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.15%
33,349
$588,276 31 Dec 2024
13F
Select Equity Group, L.P.
13F
Company
0.15%
33,175
$585,207 31 Dec 2024
13F
Daiwa Securities Group Inc.
13F
Company
0.15%
32,968
$582,000 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.14%
31,437
$554,549 31 Dec 2024
13F
Swiss National Bank
13F
Company
0.13%
30,500
$538,020 31 Dec 2024
13F
Trexquant Investment LP
13F
Company
0.13%
29,954
$528,389 31 Dec 2024
13F
MARSHALL WACE, LLP
13F
Company
0.13%
28,510
$502,916 31 Dec 2024
13F
Penn Mutual Asset Management
13F
Company
0.12%
28,281
$498,877 31 Dec 2024
13F

Institutional Holders of NRC HEALTH - National Research Ord Shs (NRC) as of Q1 2025

As of 31 Mar 2025, NRC HEALTH - National Research Ord Shs (NRC) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,503,564 shares. The largest 10 holders included KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, QV Investors Inc., STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 122 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
132
Q1 2025 holders
122
Holder diff
-10
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .